Earnings live: Microsoft, Meta stocks surge with more tech earnings from Apple and Reddit on deck
Companies had a lower bar to clear coming into the quarter, as analysts tempered their expectations amid President Trump's tariffs, stocks' lofty valuations, and uncertainty about the health of the US economy.
This week, investors will be treated to another flurry of quarterly results from Big Tech companies, including Microsoft (MSFT), Apple (AAPL), Meta (META), and Amazon (AMZN). This week's reports also include updates from Spotify (SPOT), Ford (F), Procter & Gamble (PG), Boeing (BA), Starbucks (SBUX), and Qualcomm (QCOM), among others.
Data from FactSet published Friday showed that with 34% of the index having reported results, analysts expect S&P 500 companies to report a 5.6% jump in earnings per share during the second quarter.
Heading into the quarter, analysts expected S&P 500 earnings to rise 5% in Q2, which would mark the slowest pace of earnings growth since the fourth quarter of 2023.
Here are the latest updates from corporate America.
Microsoft, Meta stocks surge as post-earnings rally adds half a trillion dollars in market value
Microsoft (MSFT) and Meta (META) stocks rallied following strong earnings reports on Wednesday that outweighed concerns about artificial intelligence spending.
Combined, the two stocks have added about half a trillion dollars in market value since Wednesday's close.
Microsoft stock gained 5% at the market open after reporting strength in its cloud and AI businesses. The company joined Nvidia (NVDA) in the $4 trillion market cap club after adding more than $305 billion to its market cap.
Meta stock also surged 12% in early trading after advertising revenue grew 22%, surpassing expectations, and its Reality Labs saw a smaller loss than expected.
'The stock moves make sense — the results are that good,' D.A. Davidson head of technology research Gil Luria told Yahoo Finance following Meta's and Microsoft's earnings. 'Meta is gaining significant share in the digital advertising market, … and therefore investors have patience for the capex guidance they're providing.'
Apple Q3 earnings to give Wall Street better view of tariff impact
Yahoo Finance's Daniel Howley previews what to watch when Apple reports earnings after the bell:
Read more here.
Reddit set to report Q2 earnings as Wall Street scrutinizes daily active user growth
Reddit (RDDT) will report second quarter results after the bell on Thursday.
One key metric to watch will be daily active users, which disappointed Wall Street over the last two quarters. Changes to Google Search's algorithm could further disrupt the platform's users.
Yahoo Finance's Laura Bratton breaks down what the Street is hoping to hear from Reddit:
Read more here.
Unilever's personal care business delivers solid results, but ice cream was the standout
Unilever (UL) beat sales growth forecasts in the second quarter but reported a 50% drop in free cash flow year over year.
The ice cream business outperformed in Q2, with sales rising 7.1%, led by double-digit growth in its Magnum brand.
Unilever's ice cream business is on track to be spun off in November. The new company will be called The Magnum Ice Cream Company, and Unilever will retain a 20% stake in the company.
Reuters reports:
Read more here.
AB InBev stock sinks as volumes decline, consumers seek value and no-alcohol options
Anheuser-Busch InBev (BUD) stock is under pressure after the company missed Wall Street's estimates for revenue and volume growth, raising concerns about the overall industry.
The stock fell more than 11% on Thursday after overall volumes declined 1.9%, moving in the opposite direction of the 0.05% gain Wall Street projected. Revenue came in at $15 billion, lower than the $15.35 billion metric Wall Street expected.
Weaker volumes in China (down 7.4%) and Brazil (down 6.5%) dragged down the quarterly results.
AB InBev CEO Michel Doukeris told Yahoo Finance that the business is over-indexed in China to bars and restaurants instead of at-home consumption and the eastern region of the country, causing it to "underperform the industry."
Brazil experienced poor weather and a value-seeking consumer, but he said he remains confident in the "industry performance [there] over the long run."
In the US, he said consumers are being "choiceful" as the industry overall experienced softness. Sales to retailers fell 2.1% in the quarter.
Doukeris said its Busch Light brand is growing as consumers, especially the low-income cohort, seek out value options after years of inflationary pressure.
The company is also responding to consumers' focus on health and wellness, with low-calorie brands like Michelob Ultra, and a consumer shift away from alcohol. Doukeris believes the global portfolio is still well-positioned to meet this demand, with brands like Corona Cero and Cass Zero in Korea.
"This idea of low calories, low carbs, low alcohol, no alcohol, gluten free, sugar free are innovations that are addressing an increasing demand for consumers to continue to be social, enjoying their moments, but more in control of their entire consumption," Doukeris said.
Thursday's trading session marks AB InBev's lowest stock price since the COVID-19 pandemic's bear market on March 16, 2020. Molson Coors (TAP) and Constellation Brands (STZ) stock also came under pressure.
CoreWeave soars after Microsoft reports higher than expected capital expenditures
CoreWeave (CRWV) shares surged more than 12% Thursday on the heels of strong earnings reports from two of its customers, Microsoft (MSFT) and Meta (META).
Microsoft is CoreWeave's largest customer, accounting for 72% of its revenue in the burgeoning cloud provider's most recent quarterly earnings report. Microsoft in its fourth quarter report (for the three months that ended June 30) spending $88.2 billion in its fiscal year 2025, ahead of the $80 billion it previously forecast. That figure represented a 58% increase in the tech giant's spending from the prior year.
Microsoft said its spending will grow at a slower pace in its 2026 fiscal year. During the first quarter, it expects to spend $30 billion, a 50% increase from the prior year.
"We will continue to invest against the expansive opportunity ahead across both capital expenditures and operating expenses given our leadership position in commercial cloud, strong demand signals for our cloud and AI offerings, and significant contracted backlog," said Microsoft CFO Amy Hood in a post earnings call with analysts.
Kellanova misses quarterly profit estimates amid US consumer spending squeeze
Kellanova (K) missed Wall Street estimates for second quarter profit on Thursday as demand softened for snacks and ready-to-eat breakfast items.
"Demand softness in most of our categories did not improve as much as we had hoped," CEO Steve Cahillane said about the quarter, per Reuters.
Kellanova reported adjusted profit of $0.93 per share in the quarter, missing market expectations of $0.99, according to data compiled by LSEG. The company reported net sales of $3.2 billion, nearly in line with analysts' expectations of $3.19 billion.
Kellanova, which spun off from the Kellogg Company in 2023, is awaiting completion of its takeover by Mars for $36 billion. Mars' acquisition of the company is expected to close at the end of 2025.
Read more here.
Mastercard says consumer remains healthy, beats on earnings
Consumer spending remains fundamentally healthy despite macroeconomic uncertainty, Mastercard (MA) executives said on its second quarter earnings call Thursday.
The total value of transactions that Mastercard processed rose 9% during the quarter, while cross-border volume, which tracks spending on cards outside their country of issue, jumped 15%.
The credit card data echoed that of Visa (V) in pointing to continued consumer appetite for travel and leisure.
Adjusted earnings per share of $4.15 beat Wall Street estimates of $4.03 per share, according to LSEG data. Net revenue rose 17% to $8.1 billion, topping estimates of $7.97 billion.
For the full year, Mastercard expects consumer spending to hold up for the rest of the year and tightened its outlook for net revenue to the high end of its previous guidance — with growth in the low teens.
Read more here from Reuters or listen to the earnings call here.
Roblox raises annual bookings forecast as viral hits spur spending boom
Roblox's (RBLX) daily active users rose 41% in the second quarter to cross 100 million, the company reported on Thursday. Roblox stock soared 19% in premarket trading.
Roblox also raised its forecast for annual bookings in the third quarter to $1.59 billion to $1.64 billion. Bookings for the second quarter came in at $1.44 billion, beating market estimates of $1.24 billion.
Reuters reports that the company has been investing in search and discovery features that allow greater visibility for viral games like "Grow a Garden." Roblox also aims to diversify its revenue beyond gaming by turning the platform into a hub for socializing, commerce, and advertising.
The platform saw a boost in engagement during the quarter, with engaged hours up 58% to 27.4 billion.
Read more here.
Bristol Myers posts better-than-expected second quarter results on strength of top sellers
Bristol Myers Squibb (BMY) reported strong sales of its bestselling drugs Eliquis and Opdivo, which boosted overall second quarter results.
Revenue rose 1% to $12.3 billion. Analysts were expecting revenue to fall to $11.4 billion due to the loss of some patents. Earnings for the company were $1.46 per share, above the $1.07 per share result expected.
Shares rose about 3% in premarket trading.
Reuters reports:
Read more here.
CVS beats Wall Street estimates in Q2, marking turnaround for pressured stock
Yahoo Finance's Anjalee Khemlani reports:
Read more here.
'Epic' boost drives Comcast's quarterly results
Reuters reports:
Read more here.
Carvana posts higher quarterly profit on record car sales
Online used-car seller Carvana's (CVNA) strong second quarter results and outlook defied Wall Street's expectations, sending its shares up over 15% in premarket trading
Bloomberg reports:
Read more here.
BMW sticks with guidance despite profit drop, Trump's tariffs
German carmaker BMW (BMW.DE) maintained its full-year guidance on Thursday despite President Trump's tariffs. The company's quarterly earnings also dropped by a third, arguing that its large manufacturing presence in the country gives it an edge over rivals.
Reuters reports
Read more here.
AB InBev shares slide on concern over sales volumes
Beer giant Anheuser-Busch InBev (BUD) stock slumped more than 9% before the bell on Thursday after reporting that its second quarter sales volumes fell more than expected due to weak demand in Brazil and China, adding to investor worries over industry growth and hitting its shares.
Reuters reports:
Read more here.
Profit-taking in Robinhood
The only problem I see in Robinhood's (HOOD) earnings numbers out last night is that the market had them priced in!
Robinhood's stock has been on fire, so I think what we are seeing in the minor premarket pullback is classic profit-taking.
A couple good points on this from Bernstein's Gautam Chhugani this morning:
Check ou y recent chat with Robinhood co-founder & CEO Vlad Tenev for more context. Tenev will also be a featured speaker at our November Invest conference.
Qualcomm on the move lower
Qualcomm's (QCOM) not playing in the big-cap tech stock euphoria this morning led by Microsoft (MSFT) and Meta (META) post earnings. Its shares are down 6% premarket.
The company's earnings late Wednesday were fine. But the Street is calling out a few things that are giving the bears the win, for now.
This note from HSBC's Ryan Mellor this morning captures it all nicely:
This is remarkable on Meta
Meta (META) is rocking premarket to the tune of 12% after a monster quarter.
Got to love the market ignoring this capex stuff in the earnings release below and focusing in on Meta's revenue trends (strong):
"We currently expect 2025 capital expenditures, including principal payments on finance leases, to be in the range of $66-72 billion, narrowed from our prior outlook of $64-72 billion and up approximately $30 billion year-over-year at the mid-point. While the infrastructure planning process remains highly dynamic, we currently expect another year of similarly significant capital expenditures dollar growth in 2026 as we continue aggressively pursuing opportunities to bring additional capacity online to meet the needs of our artificial intelligence efforts and business operations."
Bottom line: bull market... carry on!
Microsoft earnings call: A quick take
A bit of a sleepy earnings call from Microsoft (MSFT) after the close, filled with the typical tech jargon from CEO Satya Nadella.
Bottom line is this: Azure sales crushed, and there were zero signs of peaking AI demand. That should be good enough for the bulls.
"We expect stock to trade up given continued large Azure growth beats and a positive AI trajectory even with continued capacity constraints. We think this also bodes well for other AI infrastructure names in our coverage (Oracle (ORCL), Coreweave (CRWV)," Citi analyst Tyler Radke said.
Arm announces it will develop own chips, forecast fails to impress
Chip architecture provider Arm Holdings (ARM) announced it will invest in making its own chips, marking a major shift to its model of licensing chip blueprints to other companies.
Reuters reports:
Revenue increased 14% during the quarter to $1.05 billion, coming in just shy of Wall Street's estimates. Earnings per share were $0.35, in line with estimates.
Arm expects current-quarter revenue between $1.01 billion and $1.11 billion, disappointing investors hoping for a greater artificial intelligence boost.
Shares fell 8% after the market close on Wednesday.
Rad more here.
Microsoft (MSFT) and Meta (META) stocks rallied following strong earnings reports on Wednesday that outweighed concerns about artificial intelligence spending.
Combined, the two stocks have added about half a trillion dollars in market value since Wednesday's close.
Microsoft stock gained 5% at the market open after reporting strength in its cloud and AI businesses. The company joined Nvidia (NVDA) in the $4 trillion market cap club after adding more than $305 billion to its market cap.
Meta stock also surged 12% in early trading after advertising revenue grew 22%, surpassing expectations, and its Reality Labs saw a smaller loss than expected.
'The stock moves make sense — the results are that good,' D.A. Davidson head of technology research Gil Luria told Yahoo Finance following Meta's and Microsoft's earnings. 'Meta is gaining significant share in the digital advertising market, … and therefore investors have patience for the capex guidance they're providing.'
Apple Q3 earnings to give Wall Street better view of tariff impact
Yahoo Finance's Daniel Howley previews what to watch when Apple reports earnings after the bell:
Read more here.
Yahoo Finance's Daniel Howley previews what to watch when Apple reports earnings after the bell:
Read more here.
Reddit set to report Q2 earnings as Wall Street scrutinizes daily active user growth
Reddit (RDDT) will report second quarter results after the bell on Thursday.
One key metric to watch will be daily active users, which disappointed Wall Street over the last two quarters. Changes to Google Search's algorithm could further disrupt the platform's users.
Yahoo Finance's Laura Bratton breaks down what the Street is hoping to hear from Reddit:
Read more here.
Reddit (RDDT) will report second quarter results after the bell on Thursday.
One key metric to watch will be daily active users, which disappointed Wall Street over the last two quarters. Changes to Google Search's algorithm could further disrupt the platform's users.
Yahoo Finance's Laura Bratton breaks down what the Street is hoping to hear from Reddit:
Read more here.
Unilever's personal care business delivers solid results, but ice cream was the standout
Unilever (UL) beat sales growth forecasts in the second quarter but reported a 50% drop in free cash flow year over year.
The ice cream business outperformed in Q2, with sales rising 7.1%, led by double-digit growth in its Magnum brand.
Unilever's ice cream business is on track to be spun off in November. The new company will be called The Magnum Ice Cream Company, and Unilever will retain a 20% stake in the company.
Reuters reports:
Read more here.
Unilever (UL) beat sales growth forecasts in the second quarter but reported a 50% drop in free cash flow year over year.
The ice cream business outperformed in Q2, with sales rising 7.1%, led by double-digit growth in its Magnum brand.
Unilever's ice cream business is on track to be spun off in November. The new company will be called The Magnum Ice Cream Company, and Unilever will retain a 20% stake in the company.
Reuters reports:
Read more here.
AB InBev stock sinks as volumes decline, consumers seek value and no-alcohol options
Anheuser-Busch InBev (BUD) stock is under pressure after the company missed Wall Street's estimates for revenue and volume growth, raising concerns about the overall industry.
The stock fell more than 11% on Thursday after overall volumes declined 1.9%, moving in the opposite direction of the 0.05% gain Wall Street projected. Revenue came in at $15 billion, lower than the $15.35 billion metric Wall Street expected.
Weaker volumes in China (down 7.4%) and Brazil (down 6.5%) dragged down the quarterly results.
AB InBev CEO Michel Doukeris told Yahoo Finance that the business is over-indexed in China to bars and restaurants instead of at-home consumption and the eastern region of the country, causing it to "underperform the industry."
Brazil experienced poor weather and a value-seeking consumer, but he said he remains confident in the "industry performance [there] over the long run."
In the US, he said consumers are being "choiceful" as the industry overall experienced softness. Sales to retailers fell 2.1% in the quarter.
Doukeris said its Busch Light brand is growing as consumers, especially the low-income cohort, seek out value options after years of inflationary pressure.
The company is also responding to consumers' focus on health and wellness, with low-calorie brands like Michelob Ultra, and a consumer shift away from alcohol. Doukeris believes the global portfolio is still well-positioned to meet this demand, with brands like Corona Cero and Cass Zero in Korea.
"This idea of low calories, low carbs, low alcohol, no alcohol, gluten free, sugar free are innovations that are addressing an increasing demand for consumers to continue to be social, enjoying their moments, but more in control of their entire consumption," Doukeris said.
Thursday's trading session marks AB InBev's lowest stock price since the COVID-19 pandemic's bear market on March 16, 2020. Molson Coors (TAP) and Constellation Brands (STZ) stock also came under pressure.
Anheuser-Busch InBev (BUD) stock is under pressure after the company missed Wall Street's estimates for revenue and volume growth, raising concerns about the overall industry.
The stock fell more than 11% on Thursday after overall volumes declined 1.9%, moving in the opposite direction of the 0.05% gain Wall Street projected. Revenue came in at $15 billion, lower than the $15.35 billion metric Wall Street expected.
Weaker volumes in China (down 7.4%) and Brazil (down 6.5%) dragged down the quarterly results.
AB InBev CEO Michel Doukeris told Yahoo Finance that the business is over-indexed in China to bars and restaurants instead of at-home consumption and the eastern region of the country, causing it to "underperform the industry."
Brazil experienced poor weather and a value-seeking consumer, but he said he remains confident in the "industry performance [there] over the long run."
In the US, he said consumers are being "choiceful" as the industry overall experienced softness. Sales to retailers fell 2.1% in the quarter.
Doukeris said its Busch Light brand is growing as consumers, especially the low-income cohort, seek out value options after years of inflationary pressure.
The company is also responding to consumers' focus on health and wellness, with low-calorie brands like Michelob Ultra, and a consumer shift away from alcohol. Doukeris believes the global portfolio is still well-positioned to meet this demand, with brands like Corona Cero and Cass Zero in Korea.
"This idea of low calories, low carbs, low alcohol, no alcohol, gluten free, sugar free are innovations that are addressing an increasing demand for consumers to continue to be social, enjoying their moments, but more in control of their entire consumption," Doukeris said.
Thursday's trading session marks AB InBev's lowest stock price since the COVID-19 pandemic's bear market on March 16, 2020. Molson Coors (TAP) and Constellation Brands (STZ) stock also came under pressure.
CoreWeave soars after Microsoft reports higher than expected capital expenditures
CoreWeave (CRWV) shares surged more than 12% Thursday on the heels of strong earnings reports from two of its customers, Microsoft (MSFT) and Meta (META).
Microsoft is CoreWeave's largest customer, accounting for 72% of its revenue in the burgeoning cloud provider's most recent quarterly earnings report. Microsoft in its fourth quarter report (for the three months that ended June 30) spending $88.2 billion in its fiscal year 2025, ahead of the $80 billion it previously forecast. That figure represented a 58% increase in the tech giant's spending from the prior year.
Microsoft said its spending will grow at a slower pace in its 2026 fiscal year. During the first quarter, it expects to spend $30 billion, a 50% increase from the prior year.
"We will continue to invest against the expansive opportunity ahead across both capital expenditures and operating expenses given our leadership position in commercial cloud, strong demand signals for our cloud and AI offerings, and significant contracted backlog," said Microsoft CFO Amy Hood in a post earnings call with analysts.
CoreWeave (CRWV) shares surged more than 12% Thursday on the heels of strong earnings reports from two of its customers, Microsoft (MSFT) and Meta (META).
Microsoft is CoreWeave's largest customer, accounting for 72% of its revenue in the burgeoning cloud provider's most recent quarterly earnings report. Microsoft in its fourth quarter report (for the three months that ended June 30) spending $88.2 billion in its fiscal year 2025, ahead of the $80 billion it previously forecast. That figure represented a 58% increase in the tech giant's spending from the prior year.
Microsoft said its spending will grow at a slower pace in its 2026 fiscal year. During the first quarter, it expects to spend $30 billion, a 50% increase from the prior year.
"We will continue to invest against the expansive opportunity ahead across both capital expenditures and operating expenses given our leadership position in commercial cloud, strong demand signals for our cloud and AI offerings, and significant contracted backlog," said Microsoft CFO Amy Hood in a post earnings call with analysts.
Kellanova misses quarterly profit estimates amid US consumer spending squeeze
Kellanova (K) missed Wall Street estimates for second quarter profit on Thursday as demand softened for snacks and ready-to-eat breakfast items.
"Demand softness in most of our categories did not improve as much as we had hoped," CEO Steve Cahillane said about the quarter, per Reuters.
Kellanova reported adjusted profit of $0.93 per share in the quarter, missing market expectations of $0.99, according to data compiled by LSEG. The company reported net sales of $3.2 billion, nearly in line with analysts' expectations of $3.19 billion.
Kellanova, which spun off from the Kellogg Company in 2023, is awaiting completion of its takeover by Mars for $36 billion. Mars' acquisition of the company is expected to close at the end of 2025.
Read more here.
Kellanova (K) missed Wall Street estimates for second quarter profit on Thursday as demand softened for snacks and ready-to-eat breakfast items.
"Demand softness in most of our categories did not improve as much as we had hoped," CEO Steve Cahillane said about the quarter, per Reuters.
Kellanova reported adjusted profit of $0.93 per share in the quarter, missing market expectations of $0.99, according to data compiled by LSEG. The company reported net sales of $3.2 billion, nearly in line with analysts' expectations of $3.19 billion.
Kellanova, which spun off from the Kellogg Company in 2023, is awaiting completion of its takeover by Mars for $36 billion. Mars' acquisition of the company is expected to close at the end of 2025.
Read more here.
Mastercard says consumer remains healthy, beats on earnings
Consumer spending remains fundamentally healthy despite macroeconomic uncertainty, Mastercard (MA) executives said on its second quarter earnings call Thursday.
The total value of transactions that Mastercard processed rose 9% during the quarter, while cross-border volume, which tracks spending on cards outside their country of issue, jumped 15%.
The credit card data echoed that of Visa (V) in pointing to continued consumer appetite for travel and leisure.
Adjusted earnings per share of $4.15 beat Wall Street estimates of $4.03 per share, according to LSEG data. Net revenue rose 17% to $8.1 billion, topping estimates of $7.97 billion.
For the full year, Mastercard expects consumer spending to hold up for the rest of the year and tightened its outlook for net revenue to the high end of its previous guidance — with growth in the low teens.
Read more here from Reuters or listen to the earnings call here.
Consumer spending remains fundamentally healthy despite macroeconomic uncertainty, Mastercard (MA) executives said on its second quarter earnings call Thursday.
The total value of transactions that Mastercard processed rose 9% during the quarter, while cross-border volume, which tracks spending on cards outside their country of issue, jumped 15%.
The credit card data echoed that of Visa (V) in pointing to continued consumer appetite for travel and leisure.
Adjusted earnings per share of $4.15 beat Wall Street estimates of $4.03 per share, according to LSEG data. Net revenue rose 17% to $8.1 billion, topping estimates of $7.97 billion.
For the full year, Mastercard expects consumer spending to hold up for the rest of the year and tightened its outlook for net revenue to the high end of its previous guidance — with growth in the low teens.
Read more here from Reuters or listen to the earnings call here.
Roblox raises annual bookings forecast as viral hits spur spending boom
Roblox's (RBLX) daily active users rose 41% in the second quarter to cross 100 million, the company reported on Thursday. Roblox stock soared 19% in premarket trading.
Roblox also raised its forecast for annual bookings in the third quarter to $1.59 billion to $1.64 billion. Bookings for the second quarter came in at $1.44 billion, beating market estimates of $1.24 billion.
Reuters reports that the company has been investing in search and discovery features that allow greater visibility for viral games like "Grow a Garden." Roblox also aims to diversify its revenue beyond gaming by turning the platform into a hub for socializing, commerce, and advertising.
The platform saw a boost in engagement during the quarter, with engaged hours up 58% to 27.4 billion.
Read more here.
Roblox's (RBLX) daily active users rose 41% in the second quarter to cross 100 million, the company reported on Thursday. Roblox stock soared 19% in premarket trading.
Roblox also raised its forecast for annual bookings in the third quarter to $1.59 billion to $1.64 billion. Bookings for the second quarter came in at $1.44 billion, beating market estimates of $1.24 billion.
Reuters reports that the company has been investing in search and discovery features that allow greater visibility for viral games like "Grow a Garden." Roblox also aims to diversify its revenue beyond gaming by turning the platform into a hub for socializing, commerce, and advertising.
The platform saw a boost in engagement during the quarter, with engaged hours up 58% to 27.4 billion.
Read more here.
Bristol Myers posts better-than-expected second quarter results on strength of top sellers
Bristol Myers Squibb (BMY) reported strong sales of its bestselling drugs Eliquis and Opdivo, which boosted overall second quarter results.
Revenue rose 1% to $12.3 billion. Analysts were expecting revenue to fall to $11.4 billion due to the loss of some patents. Earnings for the company were $1.46 per share, above the $1.07 per share result expected.
Shares rose about 3% in premarket trading.
Reuters reports:
Read more here.
Bristol Myers Squibb (BMY) reported strong sales of its bestselling drugs Eliquis and Opdivo, which boosted overall second quarter results.
Revenue rose 1% to $12.3 billion. Analysts were expecting revenue to fall to $11.4 billion due to the loss of some patents. Earnings for the company were $1.46 per share, above the $1.07 per share result expected.
Shares rose about 3% in premarket trading.
Reuters reports:
Read more here.
CVS beats Wall Street estimates in Q2, marking turnaround for pressured stock
Yahoo Finance's Anjalee Khemlani reports:
Read more here.
Yahoo Finance's Anjalee Khemlani reports:
Read more here.
'Epic' boost drives Comcast's quarterly results
Reuters reports:
Read more here.
Reuters reports:
Read more here.
Carvana posts higher quarterly profit on record car sales
Online used-car seller Carvana's (CVNA) strong second quarter results and outlook defied Wall Street's expectations, sending its shares up over 15% in premarket trading
Bloomberg reports:
Read more here.
Online used-car seller Carvana's (CVNA) strong second quarter results and outlook defied Wall Street's expectations, sending its shares up over 15% in premarket trading
Bloomberg reports:
Read more here.
BMW sticks with guidance despite profit drop, Trump's tariffs
German carmaker BMW (BMW.DE) maintained its full-year guidance on Thursday despite President Trump's tariffs. The company's quarterly earnings also dropped by a third, arguing that its large manufacturing presence in the country gives it an edge over rivals.
Reuters reports
Read more here.
German carmaker BMW (BMW.DE) maintained its full-year guidance on Thursday despite President Trump's tariffs. The company's quarterly earnings also dropped by a third, arguing that its large manufacturing presence in the country gives it an edge over rivals.
Reuters reports
Read more here.
AB InBev shares slide on concern over sales volumes
Beer giant Anheuser-Busch InBev (BUD) stock slumped more than 9% before the bell on Thursday after reporting that its second quarter sales volumes fell more than expected due to weak demand in Brazil and China, adding to investor worries over industry growth and hitting its shares.
Reuters reports:
Read more here.
Beer giant Anheuser-Busch InBev (BUD) stock slumped more than 9% before the bell on Thursday after reporting that its second quarter sales volumes fell more than expected due to weak demand in Brazil and China, adding to investor worries over industry growth and hitting its shares.
Reuters reports:
Read more here.
Profit-taking in Robinhood
The only problem I see in Robinhood's (HOOD) earnings numbers out last night is that the market had them priced in!
Robinhood's stock has been on fire, so I think what we are seeing in the minor premarket pullback is classic profit-taking.
A couple good points on this from Bernstein's Gautam Chhugani this morning:
Check ou y recent chat with Robinhood co-founder & CEO Vlad Tenev for more context. Tenev will also be a featured speaker at our November Invest conference.
The only problem I see in Robinhood's (HOOD) earnings numbers out last night is that the market had them priced in!
Robinhood's stock has been on fire, so I think what we are seeing in the minor premarket pullback is classic profit-taking.
A couple good points on this from Bernstein's Gautam Chhugani this morning:
Check ou y recent chat with Robinhood co-founder & CEO Vlad Tenev for more context. Tenev will also be a featured speaker at our November Invest conference.
Qualcomm on the move lower
Qualcomm's (QCOM) not playing in the big-cap tech stock euphoria this morning led by Microsoft (MSFT) and Meta (META) post earnings. Its shares are down 6% premarket.
The company's earnings late Wednesday were fine. But the Street is calling out a few things that are giving the bears the win, for now.
This note from HSBC's Ryan Mellor this morning captures it all nicely:
Qualcomm's (QCOM) not playing in the big-cap tech stock euphoria this morning led by Microsoft (MSFT) and Meta (META) post earnings. Its shares are down 6% premarket.
The company's earnings late Wednesday were fine. But the Street is calling out a few things that are giving the bears the win, for now.
This note from HSBC's Ryan Mellor this morning captures it all nicely:
This is remarkable on Meta
Meta (META) is rocking premarket to the tune of 12% after a monster quarter.
Got to love the market ignoring this capex stuff in the earnings release below and focusing in on Meta's revenue trends (strong):
"We currently expect 2025 capital expenditures, including principal payments on finance leases, to be in the range of $66-72 billion, narrowed from our prior outlook of $64-72 billion and up approximately $30 billion year-over-year at the mid-point. While the infrastructure planning process remains highly dynamic, we currently expect another year of similarly significant capital expenditures dollar growth in 2026 as we continue aggressively pursuing opportunities to bring additional capacity online to meet the needs of our artificial intelligence efforts and business operations."
Bottom line: bull market... carry on!
Meta (META) is rocking premarket to the tune of 12% after a monster quarter.
Got to love the market ignoring this capex stuff in the earnings release below and focusing in on Meta's revenue trends (strong):
"We currently expect 2025 capital expenditures, including principal payments on finance leases, to be in the range of $66-72 billion, narrowed from our prior outlook of $64-72 billion and up approximately $30 billion year-over-year at the mid-point. While the infrastructure planning process remains highly dynamic, we currently expect another year of similarly significant capital expenditures dollar growth in 2026 as we continue aggressively pursuing opportunities to bring additional capacity online to meet the needs of our artificial intelligence efforts and business operations."
Bottom line: bull market... carry on!
Microsoft earnings call: A quick take
A bit of a sleepy earnings call from Microsoft (MSFT) after the close, filled with the typical tech jargon from CEO Satya Nadella.
Bottom line is this: Azure sales crushed, and there were zero signs of peaking AI demand. That should be good enough for the bulls.
"We expect stock to trade up given continued large Azure growth beats and a positive AI trajectory even with continued capacity constraints. We think this also bodes well for other AI infrastructure names in our coverage (Oracle (ORCL), Coreweave (CRWV)," Citi analyst Tyler Radke said.
A bit of a sleepy earnings call from Microsoft (MSFT) after the close, filled with the typical tech jargon from CEO Satya Nadella.
Bottom line is this: Azure sales crushed, and there were zero signs of peaking AI demand. That should be good enough for the bulls.
"We expect stock to trade up given continued large Azure growth beats and a positive AI trajectory even with continued capacity constraints. We think this also bodes well for other AI infrastructure names in our coverage (Oracle (ORCL), Coreweave (CRWV)," Citi analyst Tyler Radke said.
Arm announces it will develop own chips, forecast fails to impress
Chip architecture provider Arm Holdings (ARM) announced it will invest in making its own chips, marking a major shift to its model of licensing chip blueprints to other companies.
Reuters reports:
Revenue increased 14% during the quarter to $1.05 billion, coming in just shy of Wall Street's estimates. Earnings per share were $0.35, in line with estimates.
Arm expects current-quarter revenue between $1.01 billion and $1.11 billion, disappointing investors hoping for a greater artificial intelligence boost.
Shares fell 8% after the market close on Wednesday.
Rad more here.
Chip architecture provider Arm Holdings (ARM) announced it will invest in making its own chips, marking a major shift to its model of licensing chip blueprints to other companies.
Reuters reports:
Revenue increased 14% during the quarter to $1.05 billion, coming in just shy of Wall Street's estimates. Earnings per share were $0.35, in line with estimates.
Arm expects current-quarter revenue between $1.01 billion and $1.11 billion, disappointing investors hoping for a greater artificial intelligence boost.
Shares fell 8% after the market close on Wednesday.
Rad more here.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Morning Bid: Buy the dip, we can worry about jobs later
(Reuters) -A look at the day ahead in European and global markets from Wayne Cole. It's been a case of buy the dip so far on Monday as U.S. and European stock futures edge up, along with the dollar. The Nikkei suffered a delayed reaction to Friday's Wall Street rout and a jump in the yen, but the rest of Asia fared better. Early trade saw Fed fund futures price in 65 bps of interest rate cuts by December, but that's back to 60 bps now. That's still a world away from the 33 bps seen before Friday's weak U.S. payrolls report, and September is still 83% for an easing. In fact, the 25 bps drop in two-year yields on Friday was essentially the market doing a Fed rate cut for them, given how borrowing costs in the States are tied to yields not the funds rate. Ten-year yields also fell a steep 14 bps but met resistance around 4.20%, a level they have repeatedly struggled to break under since October last year. Longer term, downward revisions to payrolls have seriously challenged the U.S. claim to economic out-performance and the dollar's crown of exceptionalism. The latter was also tarnished by President Trump firing the head of the Bureau of Labor Statistics, an institution with an invaluable reputation for scrupulous honesty that won the trust of investors worldwide. Or, at least, it used to be. Now, Trump says he will chose a new head for the BLS in the next few days. Will it be an independent-minded statistician dedicated to providing credible data, or a Trump loyalist eager to please their master? U.S. assets enjoy a trust premium that will be really hard to maintain as Trump bends all levels of government to his will. Trump also just floated the idea of using some of the windfall from tariffs to pay "dividends" to a lucky group of Americans chosen by him - no doubt with special cheques bearing a "TRUMP" logo. So you slap taxes on everyone that buys imports, whether they have a choice or not, and then use part of the revenue to pay money to those you favour, in your name rather than the government that's actually doing the work. Talking of tariffs, a U.S. appeals court late last week heard arguments on the legality of Trump's "reciprocal" levies and sounded inclined to support the original ruling that the tariffs were illegal. Such a ruling would likely still go to the Supreme Court, which has tended to favour unbridled presidential power. Yet, should the tariffs be found illegal, not only would all the trade deals agreed or underway be null and void, but the Treasury would have to refund all the money collected. Wouldn't that be fun... Key developments that could influence markets on Monday: * Swiss CPI for July Trying to keep up with the latest tariff news? Our new daily news digest offers a rundown of the top market-moving headlines impacting global trade. Sign up for Tariff Watch here. (By Wayne Cole; Editing by Christopher Cushing) Sign in to access your portfolio
Yahoo
8 minutes ago
- Yahoo
Discovering Asia's Undiscovered Gems This August 2025
As global markets grapple with renewed trade tensions and economic uncertainties, smaller-cap indices have experienced notable declines, reflecting the broader market sentiment. Amid this backdrop, investors are increasingly on the lookout for resilient stocks that can navigate these challenges and offer potential growth opportunities. In Asia's dynamic landscape, identifying such undiscovered gems requires a keen understanding of local markets and a focus on companies with strong fundamentals and innovative strategies. Top 10 Undiscovered Gems With Strong Fundamentals In Asia Name Debt To Equity Revenue Growth Earnings Growth Health Rating Chudenko NA 4.69% 17.78% ★★★★★★ Wuxi Chemical Equipment NA 13.24% -0.17% ★★★★★★ Minmetals Development 35.99% 0.88% -12.63% ★★★★★★ Jiangyin Haida Rubber And Plastic 16.31% 7.95% -9.56% ★★★★★★ Shantou Institute of Ultrasonic Instrument NA 17.40% 16.47% ★★★★★★ Yashima Denki 2.36% 1.42% 23.63% ★★★★★☆ Hangzhou Zhengqiang 26.03% 2.95% 16.75% ★★★★★☆ Jinsanjiang (Zhaoqing) Silicon Material 3.59% 18.23% -7.68% ★★★★★☆ Ningbo Henghe Precision IndustryLtd 66.02% 5.50% 23.91% ★★★★☆☆ Zhejiang Risun Intelligent TechnologyLtd 27.20% 20.30% -23.01% ★★★★☆☆ Click here to see the full list of 2576 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener. Let's review some notable picks from our screened stocks. COSCO SHIPPING International (Singapore) Simply Wall St Value Rating: ★★★★☆☆ Overview: COSCO SHIPPING International (Singapore) Co., Ltd. is an investment holding company that offers integrated logistics services across South and Southeast Asia, with a market capitalization of SGD550.85 million. Operations: COSCO SHIPPING International (Singapore) derives its revenue primarily from logistics, contributing SGD149.87 million, and ship repair and marine-related activities, which add SGD20.14 million. Property management also contributes to the revenue with SGD3.45 million. The company's financial performance is influenced by its net profit margin trends over the periods analyzed. COSCO SHIPPING International (Singapore) showcases a stable financial footing with a net debt to equity ratio of 22.1%, deemed satisfactory, and interest payments well covered by EBIT at 3.7 times. Despite an impressive earnings growth of 188.1% over the past year, it slightly lagged behind the broader logistics industry at 193.5%. The company has been proactive in expanding its operations, with construction underway for the Jurong Island Logistics Hub Phase II, expected to complete by late 2026. However, shareholders faced substantial dilution recently due to a SGD 273 million rights offering completed in July 2025. Delve into the full analysis health report here for a deeper understanding of COSCO SHIPPING International (Singapore). Assess COSCO SHIPPING International (Singapore)'s past performance with our detailed historical performance reports. Chongqing Pharscin Pharmaceutical Simply Wall St Value Rating: ★★★★★★ Overview: Chongqing Pharscin Pharmaceutical Co., Ltd. is a company involved in the pharmaceutical industry with a market capitalization of CN¥8.66 billion. Operations: Pharscin generates its revenue primarily from pharmaceutical sales. The company recorded a market capitalization of CN¥8.66 billion. Chongqing Pharscin Pharmaceutical stands out with its recent earnings surge of 78.7%, significantly outperforming the broader Pharmaceuticals industry, which saw a -2.6% change. Despite a volatile share price over the last three months, the company maintains a debt-free status, contrasting sharply with its previous debt to equity ratio of 20.9% five years ago. A notable CN¥22.6M one-off gain has influenced recent financial outcomes, highlighting some irregularities in earnings quality. The approval of a cash dividend for 2024 and changes in board composition underscore ongoing strategic adjustments within this dynamic pharmaceutical player in Asia's market landscape. Dive into the specifics of Chongqing Pharscin Pharmaceutical here with our thorough health report. Learn about Chongqing Pharscin Pharmaceutical's historical performance. Beijing Scitop Bio-tech Simply Wall St Value Rating: ★★★★★★ Overview: Beijing Scitop Bio-tech Co., Ltd. engages in the research, development, manufacturing, and sale of probiotic lactic acid bacteria and related products in China with a market capitalization of CN¥5.38 billion. Operations: Scitop Bio-tech generates revenue primarily from the sale of probiotic lactic acid bacteria products. The company has a market capitalization of CN¥5.38 billion, reflecting its financial stature in the industry. Beijing Scitop Bio-tech, a smaller player in the biotech sector, has shown resilience with high-quality earnings and no debt over the past five years. Despite a volatile share price recently, its earnings growth of 4.6% last year surpassed the broader food industry's -5% trend. However, its free cash flow remains negative at -139.99 million CNY as of March 2025, indicating potential challenges in liquidity management. The company approved a cash dividend of CNY 1.50 per ten shares for 2024, reflecting confidence despite declining earnings by 1% annually over five years. Click here and access our complete health analysis report to understand the dynamics of Beijing Scitop Bio-tech. Evaluate Beijing Scitop Bio-tech's historical performance by accessing our past performance report. Summing It All Up Click this link to deep-dive into the 2576 companies within our Asian Undiscovered Gems With Strong Fundamentals screener. Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Ready To Venture Into Other Investment Styles? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SGX:F83 SZSE:002907 and SZSE:300858. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
8 minutes ago
- Yahoo
Middle Eastern Penny Stocks To Watch In August 2025
The Middle Eastern markets have recently experienced a downturn, with most Gulf indices falling due to weak earnings and concerns over the U.S. economy. Despite these challenges, there remain opportunities for investors willing to explore smaller or newer companies offering potential growth. While the term "penny stocks" may seem outdated, it still refers to companies that can provide significant value when backed by strong financials and a clear growth trajectory. Top 10 Penny Stocks In The Middle East Name Share Price Market Cap Financial Health Rating Big Tech 50 R&D-Limited Partnership (TASE:BIGT) ₪1.421 ₪15.08M ★★★★★★ Thob Al Aseel (SASE:4012) SAR3.86 SAR1.53B ★★★★★★ Alarum Technologies (TASE:ALAR) ₪4.188 ₪296M ★★★★★★ Mega Polietilen Köpük Sanayi ve Ticaret Anonim Sirketi (IBSE:MEGAP) TRY4.80 TRY1.32B ★★★★★☆ E7 Group PJSC (ADX:E7) AED1.52 AED3.06B ★★★★★★ Katmerciler Arac Üstü Ekipman Sanayi ve Ticaret (IBSE:KATMR) TRY2.70 TRY2.91B ★★★★★☆ Dubai National Insurance & Reinsurance (P.S.C.) (DFM:DNIR) AED3.30 AED381.15M ★★★★★★ Dubai Investments PJSC (DFM:DIC) AED2.95 AED12.5B ★★★★☆☆ Sharjah Cement and Industrial Development (PJSC) (ADX:SCIDC) AED0.816 AED496.34M ★★★★★★ Tgi Infrastructures (TASE:TGI) ₪2.57 ₪191.06M ★★★★★★ Click here to see the full list of 77 stocks from our Middle Eastern Penny Stocks screener. We're going to check out a few of the best picks from our screener tool. Al Waha Capital PJSC Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Al Waha Capital PJSC is a private equity firm managing assets across diverse sectors such as financial services, fintech, healthcare, energy, infrastructure, industrial real estate and capital markets with a market cap of AED2.99 billion. Operations: The company generates revenue from its Private Investments segment, excluding Waha Land, amounting to AED152.39 million. Market Cap: AED2.99B Al Waha Capital PJSC, with a market cap of AED2.99 billion, manages assets across various sectors and has shown a mixed financial performance. While the company has become profitable over the past five years with 30.3% annual earnings growth, recent earnings have declined by 44.3%. Its short-term assets significantly exceed both its short and long-term liabilities, indicating strong liquidity. However, operating cash flow is negative, impacting debt coverage capabilities. Despite a low return on equity of 6.6%, its price-to-earnings ratio suggests potential undervaluation compared to the broader AE market average of 13.3x. Unlock comprehensive insights into our analysis of Al Waha Capital PJSC stock in this financial health report. Learn about Al Waha Capital PJSC's historical performance here. Gencell Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: GenCell Ltd. focuses on developing and producing fuel cell-based energy systems, with a market cap of ₪26.73 million. Operations: The company generates revenue of $9.55 million from its segment dedicated to the development and production of energy systems utilizing fuel cells. Market Cap: ₪26.73M GenCell Ltd., with a market cap of ₪26.73 million, focuses on fuel cell-based energy systems and generates revenue of $9.55 million. Despite being unprofitable, it remains debt-free and has a stable board with an average tenure of 4.7 years. However, the company faces financial challenges with less than a year of cash runway and declining earnings over the past five years at 12.7% annually. Its share price has been highly volatile recently, yet shareholders have not faced significant dilution in the past year, maintaining some stability in ownership structure amidst financial uncertainty. Click to explore a detailed breakdown of our findings in Gencell's financial health report. Gain insights into Gencell's past trends and performance with our report on the company's historical track record. Unicorn Technologies - Limited Partnership Simply Wall St Financial Health Rating: ★★★★★★ Overview: Unicorn Technologies - Limited Partnership, based in Tel Aviv, Israel, operates as a principal investment firm with a market cap of ₪10.89 million. Operations: Unicorn Technologies - Limited Partnership has not reported any revenue segments. Market Cap: ₪10.89M Unicorn Technologies - Limited Partnership, with a market cap of ₪10.89 million, is pre-revenue and debt-free, offering a cash runway exceeding three years based on current free cash flow trends. Despite this financial cushion, the company struggles with profitability as its return on equity stands at -16.89%. Its board is experienced with an average tenure of 5.6 years; however, management's experience remains unclear. The stock has shown high volatility over the past three months but has not undergone significant shareholder dilution recently. A Special Shareholders Meeting is scheduled for June 24, 2025. Navigate through the intricacies of Unicorn Technologies - Limited Partnership with our comprehensive balance sheet health report here. Gain insights into Unicorn Technologies - Limited Partnership's historical outcomes by reviewing our past performance report. Make It Happen Embark on your investment journey to our 77 Middle Eastern Penny Stocks selection here. Want To Explore Some Alternatives? These 18 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ADX:WAHA TASE:GNCL and TASE:UNCT. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio